These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 26471359

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Histone Methyltransferase DOT1L Promotes Neuroblastoma by Regulating Gene Transcription.
    Wong M, Tee AEL, Milazzo G, Bell JL, Poulos RC, Atmadibrata B, Sun Y, Jing D, Ho N, Ling D, Liu PY, Zhang XD, Hüttelmaier S, Wong JWH, Wang J, Polly P, Perini G, Scarlett CJ, Liu T.
    Cancer Res; 2017 May 01; 77(9):2522-2533. PubMed ID: 28209620
    [Abstract] [Full Text] [Related]

  • 3. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
    Slack AD, Chen Z, Ludwig AD, Hicks J, Shohet JM.
    Cancer Res; 2007 Mar 15; 67(6):2448-55. PubMed ID: 17363562
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
    Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, Brors B, Beissbarth T, Vandesompele J, Pattyn F, Hero B, König R, Fischer M, Schwab M.
    Genome Biol; 2008 Oct 13; 9(10):R150. PubMed ID: 18851746
    [Abstract] [Full Text] [Related]

  • 6. Mdm2 deficiency suppresses MYCN-Driven neuroblastoma tumorigenesis in vivo.
    Chen Z, Lin Y, Barbieri E, Burlingame S, Hicks J, Ludwig A, Shohet JM.
    Neoplasia; 2009 Aug 13; 11(8):753-62. PubMed ID: 19649205
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma.
    He J, Gu L, Zhang H, Zhou M.
    Cell Cycle; 2011 Sep 01; 10(17):2994-3002. PubMed ID: 21862876
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.
    Slack A, Lozano G, Shohet JM.
    Cancer Lett; 2005 Oct 18; 228(1-2):21-7. PubMed ID: 15927364
    [Abstract] [Full Text] [Related]

  • 13. p53 is a direct transcriptional target of MYCN in neuroblastoma.
    Chen L, Iraci N, Gherardi S, Gamble LD, Wood KM, Perini G, Lunec J, Tweddle DA.
    Cancer Res; 2010 Feb 15; 70(4):1377-88. PubMed ID: 20145147
    [Abstract] [Full Text] [Related]

  • 14. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D, Gogolin S, Schroeder C, Muth D, Brueckner LM, Hess EM, Zapatka M, Theißen J, Fischer M, Ehemann V, Schwab M, Savelyeva L, Westermann F.
    Hum Mol Genet; 2013 May 01; 22(9):1735-45. PubMed ID: 23343716
    [Abstract] [Full Text] [Related]

  • 15. N-myc and noncoding RNAs in neuroblastoma.
    Buechner J, Einvik C.
    Mol Cancer Res; 2012 Oct 01; 10(10):1243-53. PubMed ID: 22936790
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Histone H3 Lysine 4 Presenter WDR5 as an Oncogenic Protein and Novel Epigenetic Target in Cancer.
    Lu K, Tao H, Si X, Chen Q.
    Front Oncol; 2018 Oct 01; 8():502. PubMed ID: 30488017
    [Abstract] [Full Text] [Related]

  • 19. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
    Fabian J, Lodrini M, Oehme I, Schier MC, Thole TM, Hielscher T, Kopp-Schneider A, Opitz L, Capper D, von Deimling A, Wiegand I, Milde T, Mahlknecht U, Westermann F, Popanda O, Roels F, Hero B, Berthold F, Fischer M, Kulozik AE, Witt O, Deubzer HE.
    Cancer Res; 2014 May 01; 74(9):2604-16. PubMed ID: 24419085
    [Abstract] [Full Text] [Related]

  • 20. The role of WDR5 in silencing human fetal globin gene expression.
    Xu Z, He Y, Ju J, Rank G, Cerruti L, Ma C, Simpson RJ, Moritz RL, Jane SM, Zhao Q.
    Haematologica; 2012 Nov 01; 97(11):1632-40. PubMed ID: 22689669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.